Takashi Fujii

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

Barbara Burtness, Kevin J. Harrington, Richard Greil et al. · The Lancet · 2019 · 3K citations · Full text

Neoadjuvant Therapy, Chemotherapy Versus Cetuximab, Medicine +7

Localized Elevation of Shear Stress Is Related to Coronary Plaque Rupture

Yusaku Fukumoto, Takafumi Hiro, Takashi Fujii et al. · Journal of the American College of Cardiology · 2008 · 264 citations

Vascular Disease, Cardiovascular Disease, Coronary Artery Disease +10

Essential role of the cryptic epitope SLAYGLR within osteopontin in a murine model of rheumatoid arthritis

N. Yamamoto, Fumihiko Sakai, Shigeyuki Kon et al. · Journal of Clinical Investigation · 2003 · 186 citations · Full text

Sclerostin, Immunology, Murine Opn +17

Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial

Jean‐Pascal Machiels, Yungan Tao, Lisa Licitra et al. · The Lancet Oncology · 2024 · 174 citations · Full text

Concurrent Chemoradiotherapy, Neoadjuvant Therapy, Squamous Cell Carcinoma +6

Clinical and Microbiological Differences between Mycobacterium abscessus and Mycobacterium massiliense Lung Diseases

Toshiyuki Harada, Yasushi Akiyama, Atsuyuki Kurashima et al. · Journal of Clinical Microbiology · 2012 · 170 citations · Full text

Pathogenic Microbiology, Pathology, Medical Microbiology +17